Hydracrylic acid

Identification

Generic Name
Hydracrylic acid
DrugBank Accession Number
DB03688
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 90.0779
Monoisotopic: 90.031694058
Chemical Formula
C3H6O3
Synonyms
  • 3-Hydroxypropanoic acid
  • 3-Hydroxypropionic acid
  • beta-Hydroxypropionic acid
  • β-hydroxypropionic acid

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UPimelyl-[acyl-carrier protein] methyl ester esteraseNot AvailableEscherichia coli (strain K12)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
PathwayCategory
Propanoate MetabolismMetabolic
Malonic AciduriaDisease
Methylmalonic Aciduria Due to Cobalamin-Related DisordersDisease
Malonyl-CoA Decarboxylase DeficiencyDisease
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as beta hydroxy acids and derivatives. These are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Hydroxy acids and derivatives
Sub Class
Beta hydroxy acids and derivatives
Direct Parent
Beta hydroxy acids and derivatives
Alternative Parents
Monocarboxylic acids and derivatives / Carboxylic acids / Primary alcohols / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Alcohol / Aliphatic acyclic compound / Beta-hydroxy acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Organic oxygen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
3-hydroxy monocarboxylic acid, omega-hydroxy fatty acid (CHEBI:33404)
Affected organisms
Not Available

Chemical Identifiers

UNII
C4ZF6XLD2X
CAS number
503-66-2
InChI Key
ALRHLSYJTWAHJZ-UHFFFAOYSA-N
InChI
InChI=1S/C3H6O3/c4-2-1-3(5)6/h4H,1-2H2,(H,5,6)
IUPAC Name
3-hydroxypropanoic acid
SMILES
OCCC(O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0000700
KEGG Compound
C01013
PubChem Compound
68152
PubChem Substance
46508403
ChemSpider
61460
ChEBI
33404
ChEMBL
CHEMBL1205969
ZINC
ZINC000000895452
PDBe Ligand
3OH
Wikipedia
3-Hydroxypropionic_acid
PDB Entries
1m33 / 3s8h / 5y8o / 5y8p / 6xb9 / 7ms1 / 7ms3 / 7ms8 / 7ms9

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility647.0 mg/mLALOGPS
logP-0.95ALOGPS
logP-0.8Chemaxon
logS0.86ALOGPS
pKa (Strongest Acidic)4.2Chemaxon
pKa (Strongest Basic)-2.5Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area57.53 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity19.05 m3·mol-1Chemaxon
Polarizability8.15 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9305
Blood Brain Barrier+0.818
Caco-2 permeable-0.5772
P-glycoprotein substrateNon-substrate0.7849
P-glycoprotein inhibitor INon-inhibitor0.9723
P-glycoprotein inhibitor IINon-inhibitor0.9707
Renal organic cation transporterNon-inhibitor0.9256
CYP450 2C9 substrateNon-substrate0.8478
CYP450 2D6 substrateNon-substrate0.9004
CYP450 3A4 substrateNon-substrate0.7941
CYP450 1A2 substrateNon-inhibitor0.8297
CYP450 2C9 inhibitorNon-inhibitor0.9443
CYP450 2D6 inhibitorNon-inhibitor0.9582
CYP450 2C19 inhibitorNon-inhibitor0.95
CYP450 3A4 inhibitorNon-inhibitor0.9343
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9779
Ames testNon AMES toxic0.9211
CarcinogenicityNon-carcinogens0.7613
BiodegradationReady biodegradable0.9714
Rat acute toxicity1.5815 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9709
hERG inhibition (predictor II)Non-inhibitor0.9625
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0007-9000000000-9aeb0d9c81f19a27c424
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-0900000000-26c10a7c09d2819f18b3
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0fba-0900000000-8bf04c0af8fd2e3b58de
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-00di-9000000000-3f5b72b8462bfcb4f391
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-00di-9000000000-3e9fa999dd5a46584db4
MS/MS Spectrum - Quattro_QQQ 40V, PositiveLC-MS/MSsplash10-03fu-5900000000-bd7d31d2678f47785461
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-000i-9000000000-d440d21b0f161a9853f1
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-0a4r-9000000000-242c99f8bca595fe224e
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-052f-9000000000-a9bac0e4116df119abb1
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-0006-9000000000-081d862d9b4bc28ae21b
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, NegativeLC-MS/MSsplash10-0006-9000000000-be05ae87088e43aa060d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-000i-9000000000-d440d21b0f161a9853f1
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0a4r-9000000000-dba7e70fabc7dac6fe4b
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-052f-9000000000-a9bac0e4116df119abb1
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-081d862d9b4bc28ae21b
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0006-9000000000-be05ae87088e43aa060d
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-00dj-9000000000-8a81150fdc1b40a19c98
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-000i-9000000000-558f663aa8d14885d55b
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-052e-9000000000-ee293a5ea21c62331987
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-2abbf14fbb1ce3143d9f
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-052b-9000000000-4791b0502714905b1006
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-2c5cd87e973eff84abe5
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-109.3003215
predicted
DarkChem Lite v0.1.0
[M-H]-109.3367215
predicted
DarkChem Lite v0.1.0
[M-H]-109.3057215
predicted
DarkChem Lite v0.1.0
[M-H]-129.52148
predicted
DeepCCS 1.0 (2019)
[M+H]+110.8528215
predicted
DarkChem Lite v0.1.0
[M+H]+108.0632215
predicted
DarkChem Lite v0.1.0
[M+H]+110.7951215
predicted
DarkChem Lite v0.1.0
[M+H]+132.31895
predicted
DeepCCS 1.0 (2019)
[M+Na]+108.7876215
predicted
DarkChem Lite v0.1.0
[M+Na]+108.8213215
predicted
DarkChem Lite v0.1.0
[M+Na]+108.7862215
predicted
DarkChem Lite v0.1.0
[M+Na]+140.5411
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Escherichia coli (strain K12)
Pharmacological action
Unknown
General Function
Pimelyl-[acyl-carrier protein] methyl ester esterase activity
Specific Function
The physiological role of BioH is to remove the methyl group introduced by BioC when the pimeloyl moiety is complete. It allows to synthesize pimeloyl-ACP via the fatty acid synthetic pathway throu...
Gene Name
bioH
Uniprot ID
P13001
Uniprot Name
Pimeloyl-[acyl-carrier protein] methyl ester esterase
Molecular Weight
28504.785 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52